A Review: Recent Advancements in treatment of Cancer Research
DOI:
https://doi.org/10.62752/sy8exb02Keywords:
Cancer, Immunotherapy, Precision medicine, Cancer metabolismAbstract
The treatment of cancer has taken a remarkable new direction with the advent of innovative scientific and technological methods. Immunotherapy has revolutionized oncology by harnessing the body's immune system to identify and destroy cancerous cells, leading to long-term remissions in many cancer types. Precision medicine enhances treatment effectiveness by tailoring therapeutic interventions to individual patients based on genetic, environmental, and lifestyle factors, thereby reducing both efficacy and adverse effects. The development of liquid biopsy methods enables non-invasive, real-time cancer detection and monitoring through blood samples (circulating tumor DNA and other biomarkers), allowing for treatment adjustments based on early cancer diagnosis. Recent advancements in CRISPR-Cas9 gene editing have opened new avenues for correcting oncogenic mutations and developing gene-based treatments. The use of artificial intelligence (AI) in cancer diagnostics, prognostics, and drug discovery is becoming increasingly common, enhancing prediction accuracy and optimizing predictive treatment planning. Combination therapies have shown synergistic potential to boost therapeutic effects and overcome drug resistance mechanisms. Meanwhile, cancer metabolism studies aim to exploit the metabolic changes in cancerous cells for therapeutic benefit. Epigenetic therapeutics seek to reverse abnormal genomic developmental control by restoring normal cellular epigenetic patterns and functions. Additionally, research on microbiomes is uncovering the crucial role of gut and tissue microbiota in cancer initiation, progression, and therapy response, suggesting potential new prevention and treatment strategies. These interdisciplinary innovations represent a paradigm shift towards more effective, personalized, and sustainable cancer care, offering new hope for improved patient survival and quality of life.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pharmacytalk2us

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in the International Journal of Pharmaceutical and Healthcare Innovation (IJPHI) are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0). Authors retain copyright of their work and grant the journal the right of first publication. The published material may be used, shared, and reproduced for non-commercial purposes with proper attribution.
© IJPHI GLOBAL PUBLISHER PVT. LTD.








